Five-year outcomes of CD19 followed by CD22 chimeric antigen receptor T-cell therapy in B-cell acute lymphoblastic leukemia patients who relapsed after allo-transplantation by Shuangyou Liu, Lihong An, Zhichao Yin, Yuehui Lin, Zhuojun Ling, Biping Deng, Xinjian Yu, Qinlong Zheng, Defeng Zhao, Tong Wu, Alex H. Chang, Chunrong Tong

Get full text